Communicable diseases

communicable diseases [109KB] In Rwanda, malaria is one of the primary causes of death for under-5s HLSP is committed to using its established expertise in both health systems development and public health to improve global and country responses in communicable disease control (CDC) as part of the wider process of achieving the Millennium Development Goals (MDGs). The MDGs set challenging global communicable disease targets for countries and development partners to reduce the incidence of malaria, tuberculosis (TB) and rotavirus (diarrhoea and vomiting in very young children) by 2015. HLSP provides both technical and managerial support to strengthen the links between public health policy, best practice in CDC programmes, including their integration into wider health systems. HLSP key strength is its ability to provide technical advice both in communicable disease control and health systems development based on over twenty years experience in over 100 countries. In many regions, the private sector has an increasing role in providing communicable disease services. HLSP advocates and supports the development of stronger government stewardship in setting and monitoring standards of care and engagement of the private sector – through programmes such as social marketing of Insecticide Treated Nets (ITNs) to reduce the transmission of malaria and franchising to improve the quality of drugs directly purchased from private sector providers. In addition to the established major global diseases, HLSP is providing support to private sector partners on emergent communicable diseases such as Avian Influenza and Severe Acute Respiratory Syndrome (SARS) in an effort to reduce transmission, understand the risks and contribute to an informed debate about their potential impact. more Sitemap Legal information Accessibility statement © Mott MacDonald 2007 - a member of the Mott MacDonald Group Site by Mott MacDonald and Radley Yeldar ›